FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916508911> ?p ?o ?g. }

• W2916508911 endingPage "98.e9" @default.
• W2916508911 startingPage "98.e1" @default.
• W2916508911 abstract "The Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP) annually publishes the immunisation schedule which, in our opinion, is considered optimal for children resident in Spain, taking into account the evidence available on current vaccines. Pneumococcal and varicella immunisation in early childhood is already included in all funded vaccines present in the regional immunisation programmes. Furthermore, this committee establishes recommendations on vaccines not included in official calendars (non-funded immunisations), such as rotavirus, meningococcal B, and meningococcal ACWY. As regards funded immunisations, 2 + 1 strategy (2, 4, 11–12 months) with hexavalent (DTaP-IPV-Hib-HB) and 13-valent pneumococcal vaccines is recommended. Administration of the 6-year booster dose with DTaP is recommended, as well as a poliomyelitis dose for children who had received the 2 + 1 scheme, with the Tdap vaccine for adolescents and pregnant women between 27 and 32 weeks gestation. The two-dose scheme should be used for MMR (12 months and 2–4 years) and varicella (15 months and 2–4 years). Coverage of human papillomavirus vaccination in girls aged 12 with a two-dose scheme (0, 6 months) should be improved. Information and recommendations for male adolescents about potential beneficial effects of the tetravalent HPV vaccine should also be provided. ACWY meningococcal vaccine is the optimal choice in adolescents. For recommended unfunded immunisations, the CAV-AEP recommends the administration of meningococcal B vaccine, due to the current availability in Spanish community pharmacies, with a 3 + 1 scheme. CAV-AEP requests the incorporation of this vaccine in the funded unified schedule. Vaccination against rotavirus is recommended in all infants. El Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP) publica anualmente el calendario de vacunaciones que estima idóneo para los niños residentes en España, teniendo en cuenta la evidencia disponible sobre vacunas. Se recogen las vacunas sistemáticas de los calendarios oficiales actuales, con las del neumococo y la varicela en la primera infancia, ya incluidas en todos ellos. Además, este comité realiza recomendaciones sobre vacunas no incluidas en los calendarios oficiales (no financiadas), como rotavirus, meningococo B y meningococo tetravalente. En cuanto a las vacunas financiadas, se sigue recomendando emplear esquemas 2 + 1 (2, 4 y 11-12 meses) con las vacunas hexavalentes y con la antineumocócica conjugada 13-valente. Se aconseja un refuerzo a los 6 años, preferentemente con DTPa, junto a una dosis de polio para aquellos que recibieron esquemas 2 + 1, así como vacunación con Tdpa en adolescentes y durante el embarazo entre las semanas 27 y 32. Se emplearán esquemas de 2 dosis para triple vírica (12 meses y 2-4 años) y varicela (15 meses y 2-4 años). Se deben incrementar las coberturas frente al papilomavirus en niñas de 12 años con 2 dosis (0-6 meses), así como informar a los varones de los beneficios potenciales de la vacunación y valorar la recomendación del preparado tetravalente. En adolescentes, la opción óptima es la vacuna antimeningocócica tetravalente. Respecto a las vacunas recomendadas no financiadas, dada su disponibilidad en las farmacias comunitarias, se recomienda la vacuna frente al meningococo B, con esquema 3 + 1, y se solicita su entrada en el calendario. Es recomendable vacunar a todos los lactantes frente al rotavirus." @default.
• W2916508911 created "2019-03-02" @default.
• W2916508911 creator A5025795271 @default.
• W2916508911 creator A5026614834 @default.
• W2916508911 creator A5029045151 @default.
• W2916508911 creator A5037965024 @default.
• W2916508911 creator A5061002664 @default.
• W2916508911 creator A5070209864 @default.
• W2916508911 creator A5076276045 @default.
• W2916508911 creator A5076517112 @default.
• W2916508911 creator A5080494879 @default.
• W2916508911 creator A5082034108 @default.
• W2916508911 creator A5090047846 @default.
• W2916508911 date "2017-02-01" @default.
• W2916508911 modified "2023-10-17" @default.
• W2916508911 title "Immunisation schedule of the Spanish Association of Paediatrics: 2017 recommendations" @default.
• W2916508911 cites W1722413884 @default.
• W2916508911 cites W1963985157 @default.
• W2916508911 cites W2044704048 @default.
• W2916508911 cites W2102788190 @default.
• W2916508911 cites W2166150748 @default.
• W2916508911 cites W2207847795 @default.
• W2916508911 cites W2255922581 @default.
• W2916508911 cites W2288619165 @default.
• W2916508911 cites W2294639738 @default.
• W2916508911 cites W2300719626 @default.
• W2916508911 cites W2313179238 @default.
• W2916508911 cites W2313256298 @default.
• W2916508911 cites W2331070081 @default.
• W2916508911 cites W2341183732 @default.
• W2916508911 cites W2343785966 @default.
• W2916508911 cites W2382524857 @default.
• W2916508911 cites W2395839121 @default.
• W2916508911 cites W2397263409 @default.
• W2916508911 cites W2404982942 @default.
• W2916508911 cites W2472751142 @default.
• W2916508911 cites W2493754065 @default.
• W2916508911 cites W2507255895 @default.
• W2916508911 cites W803022807 @default.
• W2916508911 doi "https://doi.org/10.1016/j.anpede.2016.10.009" @default.
• W2916508911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28038948" @default.
• W2916508911 hasPublicationYear "2017" @default.
• W2916508911 type Work @default.
• W2916508911 sameAs 2916508911 @default.
• W2916508911 citedByCount "1" @default.
• W2916508911 countsByYear W29165089112018 @default.
• W2916508911 crossrefType "journal-article" @default.
• W2916508911 hasAuthorship W2916508911A5025795271 @default.
• W2916508911 hasAuthorship W2916508911A5026614834 @default.
• W2916508911 hasAuthorship W2916508911A5029045151 @default.
• W2916508911 hasAuthorship W2916508911A5037965024 @default.
• W2916508911 hasAuthorship W2916508911A5061002664 @default.
• W2916508911 hasAuthorship W2916508911A5070209864 @default.
• W2916508911 hasAuthorship W2916508911A5076276045 @default.
• W2916508911 hasAuthorship W2916508911A5076517112 @default.
• W2916508911 hasAuthorship W2916508911A5080494879 @default.
• W2916508911 hasAuthorship W2916508911A5082034108 @default.
• W2916508911 hasAuthorship W2916508911A5090047846 @default.
• W2916508911 hasConcept C12590561 @default.
• W2916508911 hasConcept C147483822 @default.
• W2916508911 hasConcept C17744445 @default.
• W2916508911 hasConcept C187212893 @default.
• W2916508911 hasConcept C203014093 @default.
• W2916508911 hasConcept C22070199 @default.
• W2916508911 hasConcept C2776645655 @default.
• W2916508911 hasConcept C2778458888 @default.
• W2916508911 hasConcept C2779841045 @default.
• W2916508911 hasConcept C2780454893 @default.
• W2916508911 hasConcept C2780473352 @default.
• W2916508911 hasConcept C2780572238 @default.
• W2916508911 hasConcept C2780801004 @default.
• W2916508911 hasConcept C3017489713 @default.
• W2916508911 hasConcept C3116431 @default.
• W2916508911 hasConcept C523546767 @default.
• W2916508911 hasConcept C54355233 @default.
• W2916508911 hasConcept C71924100 @default.
• W2916508911 hasConcept C86803240 @default.
• W2916508911 hasConceptScore W2916508911C12590561 @default.
• W2916508911 hasConceptScore W2916508911C147483822 @default.
• W2916508911 hasConceptScore W2916508911C17744445 @default.
• W2916508911 hasConceptScore W2916508911C187212893 @default.
• W2916508911 hasConceptScore W2916508911C203014093 @default.
• W2916508911 hasConceptScore W2916508911C22070199 @default.
• W2916508911 hasConceptScore W2916508911C2776645655 @default.
• W2916508911 hasConceptScore W2916508911C2778458888 @default.
• W2916508911 hasConceptScore W2916508911C2779841045 @default.
• W2916508911 hasConceptScore W2916508911C2780454893 @default.
• W2916508911 hasConceptScore W2916508911C2780473352 @default.
• W2916508911 hasConceptScore W2916508911C2780572238 @default.
• W2916508911 hasConceptScore W2916508911C2780801004 @default.
• W2916508911 hasConceptScore W2916508911C3017489713 @default.
• W2916508911 hasConceptScore W2916508911C3116431 @default.
• W2916508911 hasConceptScore W2916508911C523546767 @default.
• W2916508911 hasConceptScore W2916508911C54355233 @default.
• W2916508911 hasConceptScore W2916508911C71924100 @default.
• W2916508911 hasConceptScore W2916508911C86803240 @default.
• W2916508911 hasIssue "2" @default.
• W2916508911 hasLocation W29165089111 @default.

• next